- A premixed 0.8% Lidocaine Hydrochloride and 5% Dextrose Injection containing 2 grams of Lidocaine HCl in a 250mL EXCEL® IV container, providing a high concentration of 8mg/mL
Uses
- Acute Ventricular Arrhythmias:
- Indicated for the management of ventricular arrhythmias occurring during cardiac surgery or other cardiac manipulations
- Life-Threatening Arrhythmias:
- Specifically for arrhythmias of ventricular origin, such as those occurring during an acute myocardial infarction
- Fluid-Restricted Patients:
- Indicated when therapeutic doses of lidocaine are required in a smaller fluid volume (250mL) compared to lower-concentration bags
Features
- Standardized Concentration:
- Delivers 8mg/mL, double the concentration of standard 0.4% bags, allowing for high-potency infusion
- EXCEL® IV Container:
- Flexible bag technology that is not made with PVC, DEHP, or natural rubber latex
- Ready-to-Use:
- A sterile, non-pyrogenic solution that requires no manual drug admixture, reducing contamination risk
- Tamper-Evident Ports:
- The administration set port features a plastic protector to ensure product integrity until use
- Safety Labeling:
- Includes barcodes for automated scanning to support accurate electronic medical record documentation
Benefits
- Enhanced Patient Safety:
- The non-PVC and DEHP-free design minimizes the leaching of harmful plasticizers and prevents the drug from adhering to the bag walls
- Clinical Efficiency:
- Premixed bags save time for nursing and pharmacy staff by providing a factory-measured dose ready for immediate titration
- Error Prevention:
- High-potency premixed solutions eliminate human calculation and mixing errors associated with high-alert cardiac medications
- Environmental Responsibility:
- The container is biologically inert and non-toxic, decomposing primarily into carbon dioxide and water upon incineration
Contents
- 0.4% Lidocaine Hydrochloride in 5% Dextrose for Injection in 250mL EXCEL IV Container
- 24 Containers per case
